Inspections, Compliance, Enforcement, and Criminal Investigations
Zach System S.A. - Close Out Letter 4/12/11
| Public Health Service Food and Drug Administration |
CENTER FOR DRUG EVALUATION AND RESEARCH TELEPHONE: (301) 796-3201 |
12 April 2011
Mr. Andre Edern, Deputy General Manager
ZaCh System S.A.
Zone Industrielle La Croix Cadeau B.P. 10079
Avrille Cedex 49242
France
Dear Mr. Edern:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter #320-09-12, dated 10/23/2009. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Douglas A. Campbell
Compliance Officer
International Compliance Branch





Department of Health and Human Services

